Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Non Operating Investment Income: 2024-2025

Historic Non Operating Investment Income for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $74,000.

  • Pyxis Oncology's Non Operating Investment Income fell 83.66% to $74,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$282,000, marking a year-over-year change of. This contributed to the annual value of $107,000 for FY2024, which is 69.84% up from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Non Operating Investment Income is $74,000, which was up 237.04% from -$54,000 recorded in Q2 2025.
  • Pyxis Oncology's 5-year Non Operating Investment Income high stood at $453,000 for Q3 2024, and its period low was -$181,000 during Q4 2024.
  • For the 2-year period, Pyxis Oncology's Non Operating Investment Income averaged around $857.14, with its median value being -$54,000 (2025).
  • Data for Pyxis Oncology's Non Operating Investment Income shows a peak YoY increase of 1.63% (in 2025) and a maximum YoY decrease of 83.66% (in 2025) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's Non Operating Investment Income (Quarterly) stood at -$181,000 in 2024, then tumbled by 83.66% to $74,000 in 2025.
  • Its Non Operating Investment Income was $74,000 in Q3 2025, compared to -$54,000 in Q2 2025 and -$121,000 in Q1 2025.